Jan Joseph Melenhorst, PhD

Director
Cell Therapy and Immuno-Engineering
Cleveland Clinic
Vice Chair
Immunotherapy and Precision Immuno-Oncology
Cleveland Clinic
Member
Immune Oncology Program
Case Comprehensive Cancer Center

A renowned cancer immunology expert, Dr. Melenhorst leads the cell therapy developmental therapeutics program, with a focus on translating research into novel cellular therapies for patients. As Vice Chair of the Center for Immunotherapy and Precision Immuno-Oncology, he works with experts from across Cleveland Clinic to advance research and treatment related to the rapidly growing field of immuno-oncology. The program will empower clinicians and scientists to advance personalized cellular immunotherapy and further distinguish the Cleveland area as a top hub for cellular therapy development.

Dr. Melenhorst joins Cleveland Clinic from University of Pennsylvania where he was a senior member of Dr. Carl June's Center for Cellular Immunotherapies for almost a decade. There, he was instrumental in helping bring cell therapies such as chimeric antigen receptor T cell (CAR-T) therapy into patient care. CAR-T therapy has revolutionized cancer care. His research spans basic and translational immunology with an emphasis on developing next generation immune-oncology treatments and related translational sciences. His efforts also focus on the immunobiology of CAR-T cell therapies to more safely and effectively target cancers.

Dr. Melenhorst received his PhD from Leiden University, Netherlands.

Jan Joseph Melenhorst has been pulled and future remote updates would overwrite local changes.
You can override this to make sure that future remote updates will be ignored so your local changes persist.
Resetting this later will immediately reset all local changes.
If the remote content is deleted, this content will also be deleted locally and your local changes will be lost.